145 related articles for article (PubMed ID: 36202063)
21. The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.
Sánchez-Blázquez P; Cortés-Montero E; Rodríguez-Muñoz M; Merlos M; Garzón-Niño J
Mol Brain; 2020 Nov; 13(1):150. PubMed ID: 33176836
[TBL] [Abstract][Full Text] [Related]
22. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
[TBL] [Abstract][Full Text] [Related]
23. Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands.
Zampieri D; Vio L; Fermeglia M; Pricl S; Wünsch B; Schepmann D; Romano M; Mamolo MG; Laurini E
Eur J Med Chem; 2016 Oct; 121():712-726. PubMed ID: 27366902
[TBL] [Abstract][Full Text] [Related]
24.
Agha H; McCurdy CR
RSC Med Chem; 2021 Mar; 12(2):154-177. PubMed ID: 34046607
[TBL] [Abstract][Full Text] [Related]
25. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
26. Structure-Affinity relationships of novel σ
Walby GD; Gu Q; Yang H; Martin SF
Bioorg Chem; 2024 Apr; 145():107191. PubMed ID: 38432153
[TBL] [Abstract][Full Text] [Related]
27. Development of New Benzylpiperazine Derivatives as σ
Romeo G; Bonanno F; Wilson LL; Arena E; Modica MN; Pittalà V; Salerno L; Prezzavento O; McLaughlin JP; Intagliata S
ACS Chem Neurosci; 2021 Jun; 12(11):2003-2012. PubMed ID: 34019387
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
[No Abstract] [Full Text] [Related]
29. Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists.
Katz JL; Hiranita T; Kopajtic TA; Rice KC; Mesangeau C; Narayanan S; Abdelazeem AH; McCurdy CR
J Pharmacol Exp Ther; 2016 Jul; 358(1):109-24. PubMed ID: 27189970
[TBL] [Abstract][Full Text] [Related]
30. Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.
Roy J; Kyani A; Hanafi M; Xu Y; Takyi-Williams J; Sun D; Osman EEA; Neamati N
J Med Chem; 2023 Feb; 66(3):1990-2019. PubMed ID: 36692906
[TBL] [Abstract][Full Text] [Related]
31. A role for sigma receptors in stimulant self-administration and addiction.
Katz JL; Hong WC; Hiranita T; Su TP
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):100-15. PubMed ID: 26650253
[TBL] [Abstract][Full Text] [Related]
32. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA
Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178
[TBL] [Abstract][Full Text] [Related]
33. Structure-Activity Relationships within a Series of σ
Franchini S; Sorbi C; Battisti UM; Tait A; Bencheva LI; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Benassi L; Vaschieri C; Azzoni P; Magnoni C; Brasili L
ChemMedChem; 2017 Nov; 12(22):1893-1905. PubMed ID: 28940806
[TBL] [Abstract][Full Text] [Related]
34. Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
van Waarde A; Rybczynska AA; Ramakrishnan NK; Ishiwata K; Elsinga PH; Dierckx RA
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2703-14. PubMed ID: 25173780
[TBL] [Abstract][Full Text] [Related]
35. Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.
Huang YS; Lu HL; Zhang LJ; Wu Z
Med Res Rev; 2014 May; 34(3):532-66. PubMed ID: 23922215
[TBL] [Abstract][Full Text] [Related]
36. Bicycloheptylamine-Doxorubicin Conjugate: Synthesis and Anticancer Activities in σ2 Receptor-Expressing Cell Lines.
Alamri MA; Ates-Alagoz Z; Adejare A
Med Chem; 2020; 16(2):192-201. PubMed ID: 30827254
[TBL] [Abstract][Full Text] [Related]
37. Sigma Receptor Ligands Are Potent Antiprion Compounds that Act Independently of Sigma Receptor Binding.
Mercer RCC; Le NTT; Fraser DG; Houser MCQ; Beeler AB; Harris DA
ACS Chem Neurosci; 2024 Jun; 15(11):2265-2282. PubMed ID: 38743607
[TBL] [Abstract][Full Text] [Related]
38. Early development of sigma-receptor ligands.
Narayanan S; Bhat R; Mesangeau C; Poupaert JH; McCurdy CR
Future Med Chem; 2011 Jan; 3(1):79-94. PubMed ID: 21428827
[TBL] [Abstract][Full Text] [Related]
39. Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines.
Rossi D; Rui M; Di Giacomo M; Schepmann D; Wünsch B; Monteleone S; Liedl KR; Collina S
Bioorg Med Chem; 2017 Jan; 25(1):11-19. PubMed ID: 27838169
[TBL] [Abstract][Full Text] [Related]
40. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.
Hong WC; Yano H; Hiranita T; Chin FT; McCurdy CR; Su TP; Amara SG; Katz JL
J Biol Chem; 2017 Jul; 292(27):11250-11261. PubMed ID: 28495886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
